Literature DB >> 24392364

Plasma free Fatty Acid concentrations as a marker for acute myocardial infarction.

Vijay Kumar Roy1, Anil Kumar1, Prabal Joshi2, Jyoti Arora1, Ali Mohammad Ahanger3.   

Abstract

BACKGROUND: Acute myocardial infarction carries a high mortality among cardiac patients.The discovery of the fact that certain enzymes like CPK, LDH liberated into circulation following necrosis of the myocardial cells came as boon for physicians and patients. There has been a constant search of different parameters for the diagnosis and management of CoronaryArtery Diseases (CAD). AIM: The present study was undertaken to investigate a possible relation between the changes in plasma free fatty acid (FFA) concentration and acute myocardial infarction.
MATERIAL AND METHODS: Fifty cases (25 males and 25 females) of acute myocardial infarction were selected for the present study. All the patients were in the age group of 40-70 years. For the control group fifty (25 male and 25 female) subjects of same age group were selected from patient's relatives and friends. Plasma free fatty acid concentration was estimated by Titrametric method of Trout et al., (1960), a modified version of Dole (1956). STATISTICAL ANALYSIS: The statistical analysis of the data of the present study was done by using SPSS, version 14.0.1 was used.
RESULTS: Our study showed a significant increase in plasma FFA in the first 24 hours of acute myocardial infarction with subsequent normalisation on the 7th day.The difference between the first and the seventh day was statistically significant.
CONCLUSION: The FFA were found raised in cases of acute myocardial infarction.On the basis of present study, it is worth to say that estimation of serum free fatty acid should be done routinely at the earliest opportunity in all cases of acute myocardial infarction.

Entities:  

Keywords:  Acute myocardial infarction; Coronary artery disease; FFA; Marker; Plasma free fatty acid

Year:  2013        PMID: 24392364      PMCID: PMC3879868          DOI: 10.7860/JCDR/2013/7682.3566

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  22 in total

1.  Elevated circulating free fatty acid levels impair endothelium-dependent vasodilation.

Authors:  H O Steinberg; M Tarshoby; R Monestel; G Hook; J Cronin; A Johnson; B Bayazeed; A D Baron
Journal:  J Clin Invest       Date:  1997-09-01       Impact factor: 14.808

2.  Why does atherosclerosis occur where it occurs?

Authors:  J R Schaefer; S Klumpp; B Maisch; J Krieglstein
Journal:  Atherosclerosis       Date:  2005-04-26       Impact factor: 5.162

Review 3.  Free fatty acid metabolism during myocardial ischemia and reperfusion.

Authors:  S C Hendrickson; J D St Louis; J E Lowe; S Abdel-aleem
Journal:  Mol Cell Biochem       Date:  1997-01       Impact factor: 3.396

4.  Plasma free fatty acid levels and the risk of ischemic heart disease in men: prospective results from the Québec Cardiovascular Study.

Authors:  Matteo Pirro; Pascale Mauriège; André Tchernof; Bernard Cantin; Gilles R Dagenais; Jean Pierre Després; Benoît Lamarche
Journal:  Atherosclerosis       Date:  2002-02       Impact factor: 5.162

5.  Relation between serum-free-fatty acids and arrhythmias and death after acute myocardial infarction.

Authors:  M F Oliver; V A Kurien; T W Greenwood
Journal:  Lancet       Date:  1968-04-06       Impact factor: 79.321

6.  Serum-free-fatty-acids and their relation to complications after acute myocardial infarction.

Authors:  H L Rutenberg; J C Pamintuan; L A Soloff
Journal:  Lancet       Date:  1969-09-13       Impact factor: 79.321

7.  Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production.

Authors:  H O Steinberg; G Paradisi; G Hook; K Crowder; J Cronin; A D Baron
Journal:  Diabetes       Date:  2000-07       Impact factor: 9.461

8.  High levels of nonesterified fatty acids are associated with increased familial risk of cardiovascular disease.

Authors:  M Carlsson; Y Wessman; P Almgren; L Groop
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-06       Impact factor: 8.311

9.  Circulating fatty acids, non-high density lipoprotein cholesterol, and insulin-infused fat oxidation acutely influence whole body insulin sensitivity in nondiabetic men.

Authors:  A M Poynten; S K Gan; A D Kriketos; L V Campbell; D J Chisholm
Journal:  J Clin Endocrinol Metab       Date:  2004-11-23       Impact factor: 5.958

Review 10.  Physiological regulation of NEFA availability: lipolysis pathway.

Authors:  V Stich; M Berlan
Journal:  Proc Nutr Soc       Date:  2004-05       Impact factor: 6.297

View more
  12 in total

1.  Nonesterified fatty acids and cardiovascular mortality in elderly men with CKD.

Authors:  Zibo Xiong; Hong Xu; Xiaoyan Huang; Johan Ärnlöv; Abdul Rashid Qureshi; Tommy Cederholm; Per Sjögren; Bengt Lindholm; Ulf Risérus; Juan Jesús Carrero
Journal:  Clin J Am Soc Nephrol       Date:  2015-01-30       Impact factor: 8.237

2.  Impact of high-fat, low-carbohydrate diet on myocardial substrate oxidation, insulin sensitivity, and cardiac function after ischemia-reperfusion.

Authors:  Jian Liu; Peipei Wang; Samuel L Douglas; Joshua M Tate; Simon Sham; Steven G Lloyd
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-05-06       Impact factor: 4.733

3.  The role of serum monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs) in cardiovascular disease risk.

Authors:  Jasmin Kharazmi-Khorassani; Roshanak Ghafarian Zirak; Hamideh Ghazizadeh; Reza Zare-Feyzabadi; Sara Kharazmi-Khorassani; Sharzad Naji-Reihani-Garmroudi; Elham Kazemi; Habibollah Esmaily; Ali Javan-Doust; Hamed Banpour; Maryam Mohammadi-Bajgiran; Mohhamad Reza Besharatlou; Gordon A Ferns; Mohammad Hashemi; Majid Ghayour-Mobarhan
Journal:  Acta Biomed       Date:  2021-05-12

4.  Protective role of oleic acid against cardiovascular insulin resistance and in the early and late cellular atherosclerotic process.

Authors:  Liliana Perdomo; Nuria Beneit; Yolanda F Otero; Óscar Escribano; Sabela Díaz-Castroverde; Almudena Gómez-Hernández; Manuel Benito
Journal:  Cardiovasc Diabetol       Date:  2015-06-10       Impact factor: 9.951

5.  Association between serum free fatty acid levels and possible related factors in patients with type 2 diabetes mellitus and acute myocardial infarction.

Authors:  Zhi-Hua Lv; Pei Ma; Wan Luo; Hui Xiong; Lu Han; Si-Wei Li; Xin Zhou; Jian-Cheng Tu
Journal:  BMC Cardiovasc Disord       Date:  2014-11-14       Impact factor: 2.298

Review 6.  Ischemia-Modified Albumin as a Marker of Acute Coronary Syndrome: The Case for Revising the Concept of "N-Terminal Modification" to "Fatty Acid Occupation" of Albumin.

Authors:  Ismail Oran; Bulent Oran
Journal:  Dis Markers       Date:  2017-03-05       Impact factor: 3.434

7.  Association of Serum Nonesterified Fatty Acids with Cardiovascular Event in Patients with Chronic Kidney Disease.

Authors:  Chentang Wu; Xueyun Chen
Journal:  Int J Gen Med       Date:  2021-05-24

8.  Function and Mechanism of Trimetazidine in Myocardial Infarction-Induced Myocardial Energy Metabolism Disorder Through the SIRT1-AMPK Pathway.

Authors:  Xiu-Ying Luo; Ze Zhong; Ai-Guo Chong; Wei-Wei Zhang; Xin-Dong Wu
Journal:  Front Physiol       Date:  2021-06-17       Impact factor: 4.566

9.  Free fatty acids and cardiovascular outcome: a Chinese cohort study on stable coronary artery disease.

Authors:  Hui-Wen Zhang; Xi Zhao; Yuan-Lin Guo; Cheng-Gang Zhu; Na-Qiong Wu; Jing Sun; Geng Liu; Qian Dong; Jian-Jun Li
Journal:  Nutr Metab (Lond)       Date:  2017-06-26       Impact factor: 4.169

Review 10.  Ischemia-modified albumin: Crosstalk between fatty acid and cobalt binding.

Authors:  James P C Coverdale; Kondwani G H Katundu; Amélie I S Sobczak; Swati Arya; Claudia A Blindauer; Alan J Stewart
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2018-07-20       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.